Exploratory pilot studies without filing IND [Regulatives / Guidelines]

posted by jag009  – NJ, 2017-10-02 18:12 (2684 d 16:07 ago) – Posting: # 17844
Views: 2,018

Hi,

Anyone has experience running pilot PK studies without filing an IND in USA?

Specifically, running a pilot study that compares a test product against a reference with the test product having a slight higher dose than the reference given at the maximum total daily dose. The test is designed to have the similar bioavailability(AUC) as the reference and a slower release rate(lower Cmax with longer Tmax).

I don't think it's possible because there is no in-vivo data. I don't think dissolution data alone + info from reference's original NDA about having studies conducted at higher doses would be sufficient. If the test and reference are under the same total daily dose then yes.

Thanks
J

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,664 registered users;
150 visitors (0 registered, 150 guests [including 5 identified bots]).
Forum time: 09:20 CET (Europe/Vienna)

Every system is perfectly designed
to get the results it gets.    Paul B. Batalden

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5